Disparity of serum uric acid threshold for CKD among hypertensive and non-hypertensive individuals

References

• Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):1–11. doi: 10.1016/j.kisu.2021.11.003.
   Web of Science ®Google Scholar
• Nakayama S, Satoh M, Tatsumi Y, et al. Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults. Atherosclerosis. 2021;330:107–113. doi: 10.1016/j.atherosclerosis.2021.06.908.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Sanchez Lozada LG, Lanaspa MA, et al. Uric acid and chronic kidney disease: still more to do. Kidney Int Rep. 2022;8(2):229–239. doi: 10.1016/j.ekir.2022.11.016.
   PubMed Web of Science ®Google Scholar
• Mahajan S, Feng F, Hu S, et al. Assessment of prevalence, awareness, and characteristics of isolated systolic hypertension among younger and middle-aged adults in China. JAMA Netw Open. 2020;3(12):e209743. doi: 10.1001/jamanetworkopen.2020.9743.
   PubMed Web of Science ®Google Scholar
• Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. 2022;103:4–12. doi: 10.1016/j.ejim.2022.04.022.
   PubMed Web of Science ®Google Scholar
• Gaubert M, Bardin T, Cohen-Solal A, et al. Hyperuricemia and hypertension, coronary artery disease, kidney disease: from concept to practice. Int J Mol Sci. 2020;21(11):4066. doi: 10.3390/ijms21114066.
   PubMed Web of Science ®Google Scholar
• Russo E, Verzola D, Cappadona F, et al. The role of uric acid in renal damage - a history of inflammatory pathways and vascular remodeling. VP. 2021;5:15. doi: 10.20517/2574-1209.2021.11.
   Google Scholar
• Chiang KM, Tsay YC, Vincent Ng TC, et al. Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in Han Chinese? J Clin Med. 2019;8(8):1202. doi: 10.3390/jcm8081202.
   PubMed Web of Science ®Google Scholar
• De Giorgi A, Fabbian F, Pala M, et al. Uric acid: friend or foe? Uric acid and cognitive function "gout kills more wise men than simple. Eur Rev Med Pharmacol Sci. 2015;19(4):640–646.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Maruyama Y, Nishio S, et al. Serum uric acid and the incidence of CKD and hypertension. Clin Exp Nephrol. 2015;19(6):1127–1134. doi: 10.1007/s10157-015-1120-4.
   PubMed Web of Science ®Google Scholar
• Hall JE, Mouton AJ, da Silva AA, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859–1876. doi: 10.1093/cvr/cvaa336.
   PubMed Web of Science ®Google Scholar
• Kaewput W, Thongprayoon C, Rangsin R, et al. Association between serum uric acid and chronic kidney disease in patients with hypertension: a multicenter nationwide cross-sectional study. J Evid Based Med. 2019;12(4):235–242. doi: 10.1111/jebm.12364.
   PubMedGoogle Scholar
• Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis. 2010;56(2):264–272. doi: 10.1053/j.ajkd.2010.01.019.
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Podestà MA, Moroni G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease. Kidney Int. 2020;98(5):1149–1159. doi: 10.1016/j.kint.2020.05.056.
   PubMed Web of Science ®Google Scholar
• Chen JS, Wang MX, Wang MM, et al. Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis. Eur J Med Chem. 2022;237:114379. doi: 10.1016/j.ejmech.2022.114379.
   PubMed Web of Science ®Google Scholar
• Bonino B, Leoncini G, Russo E, et al. Uric acid in CKD: has the jury come to the verdict? J Nephrol. 2020;33(4):715–724. doi: 10.1007/s40620-020-00702-7.
   PubMed Web of Science ®Google Scholar
• Evidence review for the best serum urate level target to use when treating-to-target in gout? Gout: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2022.
   Google Scholar
• Chang WX, Xu N, Kumagai T, et al. Uric acid in the follow-up determines 30% decline in estimated GFR over 2 years: a propensity score analysis. Kidney Blood Press Res. 2017;42(6):1053–1067. doi: 10.1159/000485593.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi: 10.1093/ije/dys203.
   PubMed Web of Science ®Google Scholar
• Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO expert consultation on waist circumference and waist-Hip ratio. Eur J Clin Nutr. 2010;64(1):2–5. doi: 10.1038/ejcn.2009.139.
   PubMed Web of Science ®Google Scholar
• Diabetes branch of Chinese medical association. Guidelines for the prevention and treatment of type 2 diabetes in China (2013 edition). Chin J Endocrinol Metabol. 2014;30(10):893–942.
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Liu LS. Writing group of 2010 Chinese guidelines for the management of hypertension [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
   PubMedGoogle Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi: 10.1016/S0140-6736(12)60033-6.
   PubMed Web of Science ®Google Scholar
• Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol. 2013;9(1):13–23. doi: 10.1038/nrrheum.2012.143.
   PubMed Web of Science ®Google Scholar
• Nishizawa H, Maeda N, Shimomura I. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease. Hypertens Res. 2022;45(4):635–640. doi: 10.1038/s41440-021-00840-w.
   PubMed Web of Science ®Google Scholar
• Balakumar P, Alqahtani A, Khan NA, et al. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: pathologic implications and putative pharmacologic targets. Pharmacol Res. 2020;161:105209. doi: 10.1016/j.phrs.2020.105209.
   PubMed Web of Science ®Google Scholar
• Krajčoviechová A, Wohlfahrt P, Bruthans J, et al. Longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease in hypertensive and normotensive adults. Blood Press. 2020;29(5):308–318. doi: 10.1080/08037051.2020.1763158.
   PubMed Web of Science ®Google Scholar
• Xu L, Sun H, Liu L, et al. The effects of cardiometabolic factors on the association between serum uric acid and chronic kidney disease in Chinese middle-aged and older population: a mediation analysis. Front Endocrinol. 2021;12:702138. doi: 10.3389/fendo.2021.702138.
   PubMed Web of Science ®Google Scholar
• Gherghina ME, Peride I, Tiglis M, et al. Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23(6):3188. doi: 10.3390/ijms23063188.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang XL, Fu C, et al. Soluble uric acid increases NALP3 inflammasome and interleukin-1beta expression in human primary renal proximal tubule epithelial cells through the toll-like receptor 4-mediated pathway. Int J Mol Med. 2015;35(5):1347–1354. doi: 10.3892/ijmm.2015.2148.
   PubMed Web of Science ®Google Scholar
• Toyama T, Furuichi K, Ninomiya T, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLOS One. 2013;8(8):e71810. doi: 10.1371/journal.pone.0071810.
   PubMed Web of Science ®Google Scholar
• Hayfron-Benjamin CF, van den Born BJ, Amoah AGB, et al. Associations of serum uric acid levels with macrovascular and renal microvascular dysfunction among individuals from Sub-Saharan Africa. JAMA Netw Open. 2021;4(10):e2128985. doi: 10.1001/jamanetworkopen.2021.28985.
   PubMed Web of Science ®Google Scholar
• Russo E, Viazzi F, Pontremoli R, et al. Association of uric acid with kidney function and albuminuria: the uric acid right for heArt health (URRAH) project. J Nephrol. 2022;35(1):211–221. doi: 10.1007/s40620-021-00985-4.
   PubMed Web of Science ®Google Scholar
• Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19(12):2407–2413. doi: 10.1681/ASN.2008010080.
   PubMed Web of Science ®Google Scholar
• Cao X, Wu L, Chen Z. The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China. Int Urol Nephrol. 2018;50(3):517–525. doi: 10.1007/s11255-017-1732-6.
   PubMed Web of Science ®Google Scholar
• Piani F, Sasai F, Bjornstad P, et al. Hyperuricemia and chronic kidney disease: to treat or not to treat. J Bras Nefrol. 2021;43(4):572–579. doi: 10.1590/2175-8239-JBN-2020-U002.
   PubMedGoogle Scholar
• Klauser AS, Halpern EJ, Strobl S, et al. Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout. JAMA Cardiol. 2019;4(10):1019–1028. doi: 10.1001/jamacardio.2019.3201.
   PubMed Web of Science ®Google Scholar
• Khanna P, Johnson RJ, Marder B, et al. Systemic urate deposition: an unrecognized complication of gout? J Clin Med. 2020;9(10):3204. doi: 10.1001/jamacardio.2019.3201.
   PubMed Web of Science ®Google Scholar
• Borghi C, Piani F. Uric acid and estimate of renal function. Let’s stick together. Int J Cardiol. 2020;310:157–158. doi: 10.1016/j.ijcard.2020.01.046.
   PubMed Web of Science ®Google Scholar
• Silva NR, Gonçalves CET, Gonçalves DLN, et al. Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients. BMC Nephrol. 2021;22(1):311. doi: 10.1186/s12882-021-02521-9.
   PubMed Web of Science ®Google Scholar